Junichi Shindoh - Concepedia

Author

Junichi Shindoh

Toranomon Hospital ORCID

Also Known As

Cacy, J Shindoh, J. Shindoh, J., Shindoh, JUNICHI SHINDOH, Junichi SHINDOH, Junichi Shindoh, Shindoh, J.

247

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

Toranomon Hospital The University of Tokyo The University of Texas MD Anderson Cancer Center Okinaka Memorial Institute for Medical Research Okinaka Memorial Adult Disease Research Institute

About

Junichi Shindoh is an author at Toranomon Hospital specializing in medicine, hepatology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	47	2.6K
2	Health Sciences	12	12	591
3	Engineering	1	1	86
4	Public Health	1	1	18
5	Social Sciences	1	1	30

Junichi Shindoh

104

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases Jean‐Nicolas Vauthey, Giuseppe Zimmitti, Scott Kopetz, Annals of Surgery	2013	376
Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant Junichi Shindoh, Mark J. Truty, Thomas A. Aloia, Journal of the American College of Surgeons	2012	324
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases Kristoffer W. Brudvik, Robert Jones, Felice Giuliante, Annals of Surgery	2017	266
Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach Junichi Shindoh, Jean‐Nicolas Vauthey, Giuseppe Zimmitti, Journal of the American College of Surgeons	2013	247
Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer Junichi Shindoh, Xabier de Aretxabala, Thomas A. Aloia, Annals of Surgery	2014	228
Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma Junichi Shindoh, Masatoshi Makuuchi, Yutaka Matsuyama, Journal of Hepatology Surgical OncologyHepatologyHepatocellular CarcinomaMedicineLiver Physiology	2015	216
Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases Junichi Shindoh, Evelyne M. Loyer, Scott Kopetz, Journal of Clinical Oncology	2012	210
Optimal Future Liver Remnant in Patients Treated with Extensive Preoperative Chemotherapy for Colorectal Liver Metastases Junichi Shindoh, Ching‐Wei D. Tzeng, Thomas A. Aloia, Annals of Surgical Oncology Surgical OncologyHepatologyColorectal Liver MetastasesPatients TreatedMedicine	2013	186
Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis Takashi Kokudo, Kiyoshi Hasegawa, Satoshi Yamamoto, Journal of Hepatology Surgical OncologyVenous ThrombosisHepatologySurgical TreatmentHepatitis	2014	162
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma Dario Ribero, Giuseppe Zimmitti, Thomas A. Aloia, Journal of the American College of Surgeons	2016	149

Page 1